|
||||||||||||||||||||||
|
|
Alternate Title Phase III Study of the Effect of Vitamin E and/or Selenium on Adenomatous Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000
Trial Description Studying tissue samples in the laboratory from participants receiving treatment on the Selenium and Vitamin E Cancer Prevention Trial (SELECT) SWOG-S0000 may help doctors predict a participant's response to treatment and help plan the best treatment. This phase III trial is studying the effect of vitamin E and/or selenium on colorectal polyps in men enrolled on SELECT Trial SWOG-S0000. Eligibility criteria include the following:
Final eligibility for a clinical trial is determined by the health professionals conducting the trial. Previously collected tissue samples will be studied in the laboratory. Participants' medical records will be reviewed periodically. Participants will be evaluated once a year. Important: For more details about this trial, refer to the Health Professional version of the trial summary. If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site. Trial Lead Organizations Southwest Oncology Group
Related Information PDQ® clinical trial SWOG-S0000
|
NCI Home |
Images Version |
Contact Us |
Policies |
Accessibility |
Viewing Files |
FOIA |
Site Help |
Site Map
|
A Service of the National Cancer Institute |